566 related articles for article (PubMed ID: 3884171)
21. Mutagenic activation of N-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs.
Kamano T; Mori Y; Suda K; Takahashi M; Uchida T; Takada T; Tsutsumi M; Konishi Y
Int J Pancreatol; 1996 Aug; 20(1):51-7. PubMed ID: 8872524
[TBL] [Abstract][Full Text] [Related]
22. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis.
Degawa M; Kojima M; Hashimoto Y
Mutat Res; 1985; 152(2-3):125-9. PubMed ID: 3934534
[TBL] [Abstract][Full Text] [Related]
23. The metabolism of N-nitrosobis(2-oxopropyl)amine by microsomes and hepatocytes from Fischer 344 rats.
Farrelly JG; Saavedra JE; Kupper RJ; Stewart ML
Carcinogenesis; 1987 Aug; 8(8):1095-9. PubMed ID: 3608090
[TBL] [Abstract][Full Text] [Related]
24. Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats.
Yokose Y; Yamamoto K; Nakajima A; Eimoto H; Maruyama H; Mori Y; Konishi Y
Jpn J Cancer Res; 1988 Jun; 79(6):698-704. PubMed ID: 3137196
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters.
Pour P; Wallcave L; Gingell R; Nagel D; Lawson T; Salmasi S; Tines S
Cancer Res; 1979 Oct; 39(10):3828-33. PubMed ID: 225009
[TBL] [Abstract][Full Text] [Related]
26. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
27. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
Holme JA; Haug LT; Dybing E
Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
Rumruen K; Pool BL
Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
[TBL] [Abstract][Full Text] [Related]
29. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
30. Alkylation of rodent tissue DNA induced by N-nitrosobis(2-hydroxypropyl)amine.
Kokkinakis DM
Carcinogenesis; 1992 May; 13(5):759-65. PubMed ID: 1586988
[TBL] [Abstract][Full Text] [Related]
31. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
Araki A; Muramatsu M; Matsushima T
Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
[TBL] [Abstract][Full Text] [Related]
32. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver.
Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y
Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990
[TBL] [Abstract][Full Text] [Related]
33. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
[TBL] [Abstract][Full Text] [Related]
35. Mutagenicities of N-nitrosamines on Salmonella.
Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T
Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
[TBL] [Abstract][Full Text] [Related]
36. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
Suzuki J; Kobayashi Y; Monden S; Suzuki S
Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
[TBL] [Abstract][Full Text] [Related]
37. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
38. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
Milling DM; Maddock MB
Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
[TBL] [Abstract][Full Text] [Related]
39. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
40. Involvement of lauric acid hydroxylase in the activation of beta-substituted nitrosamines.
Lawson TA
Cancer Lett; 1991 Aug; 59(2):177-82. PubMed ID: 1884375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
